
hela cells resistant bromodeoxyuridine deficient thymidine 
kinase activity. 
mutant sublines hela s3 cells resistant 
growth inhibition bromodeoxyuridine 
(budr) isolated.  resistant 
cell lines (hela bu-10, hela bu-15, 
hela bu-25, hela bu-50, hela bu-100) 
proliferated presence 10, 
15,25,50, 100 mg/ml budr, respectively. 
extracts hela bu-25, hela 
bu-50, hela bu-100 cells exhibited 
2-5% thymidine-h, deoxyuridine-h, 
bromodeoxyuridine-h phosphorylating 
activities parental hela s3 cells. 
hela bu-10 hela bu-15 cell extracts 
also deficient thymidine kinase 
activity, yielding approx. 43% 8%, 
respectively, thymidine kinase activity 
parental hela s3 cells.  deficiency 
thymidine kinase activity hela bu-100 
cells due negative feedback inhibition 
high levels budr interference 
thymidine kinase assay 
inhibitors competing enzymes 
hela bu-100 cell extracts.  following 5 weekly 
passages media lacking budr, 
hela bu-100 cells exhibit increased 
thymidine kinase activity.  moreover, 
mixtures extracts hela s3 
hela bu-100 cells displayed thymidine 
kinase activity equivalent sum 
activities extracts prepared, 
respectively, hela s3 hela 
bu-100 cells.  radioautographic studies 
shown hela s3 cells 
incubated 6 hr thymidine-h, 
35-45% nuclei heavily labeled 
radioactivity.  however, fewer hela 
bu-100 cells displayed labeled nuclei 
nuclei lightly labeled. 
hela bu-100 cell extracts contained normal 
amounts thymidylate synthetase, 
thymidilate kinase, uridine kinase activities. 
following infection vaccinia 
virus, high levels thymidine kinase activity 
induced hela bu-100 cells. 
